Stay connected:

Get connected

Share your comments

 

More on Deloitte

Learn about our site


Recently blogged

Bookmark Email Print page

Focus: Life Sciences and Health Care in emerging markets

Life sciences companies are facing increasing pressure to produce innovative treatments and cures while meeting financial objectives. While doing business in emerging markets has the potential for significant cost savings and new revenue streams, there are pitfalls. Regardless of their location, life sciences companies are likely to face a great deal of upheaval as they strive to reinvent their strategies to achieve success.

The professionals at Deloitte member firms understand the challenges facing the Life Sciences and Health Care industry. Contact us to learn more and be sure to read the related research and reports on this page.

Featured Content

 Protecting and promoting life sciences in emerging markets   Protecting and promoting life sciences in emerging markets
Innovation plays an essential role in addressing global health care needs. In an effort to increase innovation capacity and reduce development time and cost, life sciences firms are turning to emerging markets as a source of research, development and production capabilities.

Related Content

 The right spice  The right spice
The Indian pharmaceutical market is big and getting bigger, but this growth has been accompanied by uncertainty around the future of the regulatory environment, among other factors.
 Strategies for success in 2015  Strategies for success in 2015
Acquisitions, mergers and alliances are among the strategies health care companies should consider if they want to remain competitive.
 Improving operational performance  Improving operational performance
Learn how life sciences companies can leverage supply chain management to drive value and mitigate risk.
 Managing convergence in health care  Managing convergence
Life sciences firms are moving beyond traditional industry boundaries to create new health care solutions for patients and providers.
 2008 industry outlook  2008 industry outlook
Get Deloitte's perspectives on what may be ahead for Life Sciences in the areas of cost control, wellness and prevention and talent management.
 Challenge and opportunity  Challenge and opportunity
Lured by China’s stunning economic growth, multinational pharmaceutical companies are increasingly drawn to this potent new market.

Deloitte Image

 BIO2008 Annual International Convention
Learn about Deloitte's involvement at the Biotechnology Industry Organization's Annual Convention to be held June 17-20, 2008 in San Diego, CA, USA.
Deloitte Image
Life Sciences and Health Care Industry alerts
Sign up to receive email alerts from Deloitte Research.
Deloitte Image
Health Care Webcasts
Deloitte professionals discuss key Life Sciences and Health Care issues in the Dbriefs Webcasts series.